For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a series of clinical trials have led to a major shift in medical guidance — ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...

Is daily aspirin really necessary for heart disease prevention? Find out the truth behind the changing recommendations.

Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD.

The findings showed that P2Y12 inhibitors were more effective than aspirin in reducing the risk of heart attacks and strokes.

Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study.

Racial minorities and people on Medicaid were still taking baby aspirin in 2021-2023 despite guideline warnings. (JAMA) For ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

The U.S. Preventive Services Task Force issued new recommendations advising people age 60 and older to not begin taking ...